Health

UK Study Finds Rare Gene Mutation Significantly Elevates Lung Cancer Risk WASHINGTON / RankWire.AI / – A groundbreaking discovery reveals that a scarce inherited genetic mutation can increase an individual’s likelihood of developing lung cancer by approximately 25 times overall, and by about 60 times among those who have never smoked, according to a pivotal study published in the journal Science. The research, carried out by scientists at the Dana-Farber Cancer Institute in collaboration with the 23andMe Research Institute, analyzed anonymized genetic data from over 3.3 million people. The investigators pinpointed the germline variation, designated as EGFR T790M, as one of the most potent inherited risk factors for lung cancer identified so far.

India’s drug regulator has issued a public health warning regarding two whitening creams imported from Pakistan after testing revealed high levels of heavy metals. The Central Drugs Standard Control Organisation identified Goree Beauty Cream and Chandni Whitening Cream in a notice issued on September 8, emphasizing that both products are labeled as manufactured in Pakistan. The authority clarified that neither item holds the necessary authorization for import or sale within India. The heavy metals detected may pose toxic risks and health hazards, the regulator warned.

The World Health Organization reports that Ebola transmission is decreasing in several severely affected regions of the Democratic Republic of the Congo. This positive trend is most apparent in parts of Ituri province, which remains the epicenter of the outbreak. Nonetheless, the epidemic persists and is expanding in other areas. As of official data collected through September 13, there have been 7,258 confirmed cases and 3,510 deaths across seven provinces, with a case fatality ratio of 48.4% at the national level.

Results from early testing have revealed Legionella DNA in a cooling tower at Yankee Stadium, as New York City continues its investigation into a cluster of Legionnaires’ disease cases in the South Bronx. As of Tuesday night, the city confirmed 11 cases, including one fatality. Three individuals remain hospitalized. The New York City Health Department identified 10 cooling towers with positive preliminary PCR results across ZIP codes 10451 and 10456, covering parts of Melrose and Morrisania.

The World Health Organization has urged a significant scaling up of the Ebola response within the Democratic Republic of the Congo. According to Director-General Tedros Adhanom Ghebreyesus, health teams are still unable to trace every transmission chain. As of Sept. 1, the latest government data reported 6,250 confirmed cases and 3,039 deaths in Congo. The outbreak in Bundibugyo now spans 60 health zones across six provinces. Congo’s Ebola response expands as Bundibugyo transmission remains active. This outbreak marks Congo’s most extensive and deadly Ebola event on record, ranking as the second-largest Ebola outbreak worldwide after the 2014-2016 epidemic in West Africa. Ituri remains the epicenter of the crisis, accounting for approximately 85% of cases and 88% of deaths. Tedros emphasized that many fatalities involve individuals not listed as known contacts, indicating that transmission chains are still being overlooked by health teams. Community deaths and unsafe burial practices continue to pose significant challenges to containment efforts. According to Africa CDC, over 60% of fatalities in the most recent seven-day period occurred within communities. Health officials have also highlighted delays in identifying new infections and transporting patients to treatment centers. The latest government statistics show 1,439 recoveries and a case fatality rate of 48.6%, underscoring the severe impact of the Bundibugyo Ebola strain. Active Transmission Persists in Eastern Congo Despite signs of a slight decline in recent weeks

Authorities in the Democratic Republic of the Congo have begun an targeted Ebola immunization campaign in Kisangani, the administrative center of Tshopo Province, aiming to contain the country’s most severe outbreak of the virus to date. Frontline healthcare workers, emergency response personnel, and those with direct contact to confirmed cases are being prioritized during the initial rollout. Health Minister Roger Kamba confirmed that the government launched the vaccination initiative using doses of the Ervebo vaccine to protect frontline staff working in the affected eastern regions.

The European Commission has committed to purchasing €2.1 million worth of PCR tests to support the ongoing Bundibugyo Ebola outbreak. These versatile, open-platform tests are intended to enhance infection detection capabilities and bolster laboratory infrastructure amid the crisis. This procurement was arranged with the assistance of the European Health and Digital Executive Agency. The delivery process is scheduled to commence in August, providing essential diagnostic supplies as health authorities battle the rising number of cases in the Democratic Republic of the Congo.

The outbreak has led to a total of 5,208 confirmed cases and 2,476 fatalities reported by Congolese authorities as of Aug. 18. The epidemic now spans 56 health zones across six provinces situated in the eastern and northeastern regions. Authorities have also recorded 1,115 recoveries, while 730 patients remain hospitalized or in isolation.